Northpointe Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Northpointe Capital's ELV Position: Q3 2019 in Review
Northpointe Capital reduced its Elevance Health (ELV) stake by 33% in Q3 2019, selling an estimated $969K and leaving 7,228 shares worth $1.74M. The position accounts for 0.67% of the portfolio, ranked #71.
Northpointe Capital first reported a position in ELV in Q1 2015 and has held it in 17 quarters since. The position peaked at $5.64M in Q1 2019. 1,016 funds tracked by Wall St. Rank hold ELV as of Q3 2019.
- Northpointe Capital held 7,228 shares of Elevance Health worth $1.74M as of Q3 2019.
- Northpointe Capital sold 3,536 Elevance Health shares in Q3 2019, an estimated $969K.
- Elevance Health made up 0.67% of Northpointe Capital's portfolio in Q3 2019, its #71 holding.
- Northpointe Capital first reported a position in Elevance Health in Q1 2015 and has held it in 17 quarters since.
- Northpointe Capital's Elevance Health position peaked at $5.64M in Q1 2019.
- 1,016 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.
Based on Northpointe Capital's 13F filing for Q3 2019, filed 16 Oct 2019.